Nicole Gilgen

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2018 · 455 citations

Medicine, Cardiology, Pharmacology +16

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2020 · 265 citations

Medicine, Cardiology, Internal Medicine +16

Long-Term Efficacy and Safety of Biodegradable-Polymer Biolimus-Eluting Stents

Christoph Kaiser, S. Galatius, Raban Jeger et al. · Circulation · 2014 · 92 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial

Bruno Scheller, Tuomas T. Rissanen, Ahmed Farah et al. · Circulation Cardiovascular Interventions · 2022 · 68 citations

Medicine, Cardiology, Pharmacology +17

Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents

Jochen Wöhrle, Bruno Scheller, Julia Seeger et al. · JACC: Cardiovascular Interventions · 2021 · 55 citations

Medicine, Cardiology, Internal Medicine +12